对伊曲康唑和伏立康唑均耐药的禽烟曲霉菌株。
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
作者信息
Beernaert L A, Pasmans F, Van Waeyenberghe L, Dorrestein G M, Verstappen F, Vercammen F, Haesebrouck F, Martel A
机构信息
Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
出版信息
Antimicrob Agents Chemother. 2009 May;53(5):2199-201. doi: 10.1128/AAC.01492-08. Epub 2009 Mar 2.
Abstract
The in vitro susceptibilities of 59 avian Aspergillus fumigatus strains to amphotericin B, itraconazole, and voriconazole were determined using the standard microdilution broth method (CLSI M38-A2). Four isolates showed acquired resistance to itraconazole and voriconazole, harboring implications for the treatment of aspergillosis in both birds and humans.
摘要
采用标准微量稀释肉汤法（CLSI M38 - A2）测定了59株禽烟曲霉对两性霉素B、伊曲康唑和伏立康唑的体外敏感性。4株分离株对伊曲康唑和伏立康唑表现出获得性耐药，这对鸟类和人类曲霉病的治疗都有影响。
相似文献
1
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.对伊曲康唑和伏立康唑均耐药的禽烟曲霉菌株。
Antimicrob Agents Chemother. 2009 May;53(5):2199-201. doi: 10.1128/AAC.01492-08. Epub 2009 Mar 2.
2
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.引起耳霉菌病的曲霉属真菌对两性霉素B、伏立康唑和伊曲康唑的体外药敏试验
Mycoses. 2007 Nov;50(6):447-50. doi: 10.1111/j.1439-0507.2007.01409.x.
3
Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.伏立康唑（UK-109,496）、伊曲康唑和两性霉素B对烟曲霉临床分离株的体外活性比较。
J Antimicrob Chemother. 1998 Oct;42(4):531-3. doi: 10.1093/jac/42.4.531.
4
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.比较Sensititre YeastOne法与NCCLS M38 - A微量稀释法测定两性霉素B、伏立康唑和伊曲康唑对烟曲霉临床分离株的活性。
Diagn Microbiol Infect Dis. 2006 Sep;56(1):53-5. doi: 10.1016/j.diagmicrobio.2006.03.004. Epub 2006 May 2.
5
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.关于伊曲康唑和伏立康唑对1945年至1998年间培养的临床烟曲霉分离株体外活性的全国性调查。
J Clin Microbiol. 2002 Jul;40(7):2648-50. doi: 10.1128/JCM.40.7.2648-2650.2002.
6
In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.两性霉素B、伊曲康唑和伏立康唑对150株临床和环境烟曲霉分离株的体外活性。
J Antimicrob Chemother. 1998 Sep;42(3):389-92. doi: 10.1093/jac/42.3.389.
7
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.烟曲霉对伊曲康唑、伏立康唑和泊沙康唑的体外药敏性：与伏立康唑的相关性。
Antimicrob Agents Chemother. 2013 Nov;57(11):5778-80. doi: 10.1128/AAC.01141-13. Epub 2013 Sep 16.
8
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.E试验与CLSI M-38 A微量稀释法之间的相关性，用于测定两性霉素B、伏立康唑和伊曲康唑对烟曲霉临床分离株的活性。
Diagn Microbiol Infect Dis. 2007 Mar;57(3):273-6. doi: 10.1016/j.diagmicrobio.2006.09.003. Epub 2006 Dec 1.
9
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.卡泊芬净、两性霉素B和唑类药物对耐伊曲康唑烟曲霉临床分离株的体外联合活性。
Antimicrob Agents Chemother. 2005 Mar;49(3):1232-5. doi: 10.1128/AAC.49.3.1232-1235.2005.
10
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.从猎鹰呼吸道分离的真菌对两性霉素B、伊曲康唑和伏立康唑的敏感性。
Vet Rec. 2006 Aug 26;159(9):282-4. doi: 10.1136/vr.159.9.282.
引用本文的文献
1
Pan-azole resistance in clinical isolates carrying TR34/L98H from birds and mammals in Belgium.比利时鸟类和哺乳动物携带TR34/L98H的临床分离株中的泛唑耐药性。
One Health. 2024 Oct 2;19:100907. doi: 10.1016/j.onehlt.2024.100907. eCollection 2024 Dec.
2
Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands.荷兰兽医临床烟曲霉分离株的唑类耐药性。
Mycopathologia. 2024 Jun 12;189(4):50. doi: 10.1007/s11046-024-00850-5.
3
Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) in a french zoological park: evaluation of environmental exposure.法属动物园洪堡企鹅（Spheniscus humboldti）群体中的曲霉菌病：环境暴露评估。
Vet Res Commun. 2024 Feb;48(1):437-448. doi: 10.1007/s11259-023-10220-z. Epub 2023 Oct 11.
4
Emerging Fungal Infections: from the Fields to the Clinic, Resistant and Dermatophyte Species: a One Health Perspective on an Urgent Public Health Problem.新兴真菌病：从田野到临床、耐药菌与皮肤癣菌：关于一个紧迫公共卫生问题的“同一健康”视角
Curr Clin Microbiol Rep. 2022;9(4):46-51. doi: 10.1007/s40588-022-00181-3. Epub 2022 Sep 27.
5
Gaz Alafi: A Traditional Dessert in the Middle East With Anticancer, Immunomodulatory, and Antimicrobial Activities.加兹·阿拉菲：一种具有抗癌、免疫调节和抗菌活性的中东传统甜点。
Front Nutr. 2022 Jul 1;9:900506. doi: 10.3389/fnut.2022.900506. eCollection 2022.
6
Avian-associated Aspergillus fumigatus displays broad phylogenetic distribution, no evidence for host specificity, and multiple genotypes within epizootic events.禽源烟曲霉显示出广泛的系统发育分布，没有宿主特异性的证据，并且在流行事件中有多个基因型。
G3 (Bethesda). 2022 May 6;12(5). doi: 10.1093/g3journal/jkac075.
7
Aspergillosis in Wild Birds.野生鸟类中的曲霉病
J Fungi (Basel). 2021 Mar 23;7(3):241. doi: 10.3390/jof7030241.
8
Aspergillosis, Avian Species and the One Health Perspective: The Possible Importance of Birds in Azole Resistance.曲霉病、鸟类与“同一健康”视角：鸟类在唑类耐药性中可能的重要性
Microorganisms. 2020 Dec 19;8(12):2037. doi: 10.3390/microorganisms8122037.
9
Mechanisms of triazole resistance in Aspergillus fumigatus.烟曲霉中三唑类耐药机制。
Environ Microbiol. 2020 Dec;22(12):4934-4952. doi: 10.1111/1462-2920.15274. Epub 2020 Oct 21.
10
Clinical Management of Avian Renal Disease.禽肾病的临床管理
Vet Clin North Am Exot Anim Pract. 2020 Jan;23(1):75-101. doi: 10.1016/j.cvex.2019.08.004.
本文引用的文献
1
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.烟曲霉中唑类耐药性的出现及单一耐药机制的传播。
PLoS Med. 2008 Nov 11;5(11):e219. doi: 10.1371/journal.pmed.0050219.
2
Modelling Aspergillus fumigatus infections in racing pigeons (Columba livia domestica).赛鸽（家鸽）烟曲霉感染建模
Avian Pathol. 2008 Oct;37(5):545-9. doi: 10.1080/03079450802382280.
3
Designing voriconazole treatment for racing pigeons: balancing between hepatic enzyme auto induction and toxicity.赛鸽伏立康唑治疗方案的设计：肝酶自身诱导与毒性之间的平衡
Med Mycol. 2009 May;47(3):276-85. doi: 10.1080/13693780802262115. Epub 2008 Aug 4.
4
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.700多株曲霉菌临床分离株的三唑类交叉耐药性体外研究。
J Clin Microbiol. 2008 Aug;46(8):2568-72. doi: 10.1128/JCM.00535-08. Epub 2008 Jun 18.
5
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.烟曲霉中唑类药物的流行病学截断值及交叉耐药性
Antimicrob Agents Chemother. 2008 Jul;52(7):2468-72. doi: 10.1128/AAC.00156-08. Epub 2008 May 12.
6
The use of voriconazole for the treatment of aspergillosis in falcons (Falco species).伏立康唑在隼类（隼属物种）曲霉病治疗中的应用。
J Avian Med Surg. 2007 Dec;21(4):307-16. doi: 10.1647/1082-6742(2007)21[307:TUOVFT]2.0.CO;2.
7
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.烟曲霉组：抗真菌药敏模式及基于序列的鉴定
Antimicrob Agents Chemother. 2008 Apr;52(4):1244-51. doi: 10.1128/AAC.00942-07. Epub 2008 Jan 22.
8
Ergosterol biosynthesis pathway in Aspergillus fumigatus.烟曲霉中的麦角固醇生物合成途径。
Steroids. 2008 Mar;73(3):339-47. doi: 10.1016/j.steroids.2007.11.005. Epub 2007 Dec 3.
9
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.一种新的烟曲霉耐药机制可导致对唑类抗真菌药物产生体外交叉耐药性，该机制涉及cyp51A改变的组合。
Antimicrob Agents Chemother. 2007 Jun;51(6):1897-904. doi: 10.1128/AAC.01092-06. Epub 2007 Mar 19.
10
International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).念珠菌属和曲霉属的国际监测：哨兵抗菌药物监测计划（2003年）报告
J Clin Microbiol. 2006 May;44(5):1782-7. doi: 10.1128/JCM.44.5.1782-1787.2006.
Zotero 插件